Fc-fusion technology and recombinant FVIII and FIX in the management of the hemophilias
Maria Elisa Mancuso,1 Pier Mannuccio Mannucci21Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, 2Scientific Direction, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, ItalyAbstract: Prophylaxis with regular infusions of factor VIII (FVIII)- or factor IX (FIX)- containin...
I tiakina i:
| Ngā kaituhi matua: | , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
Dove Medical Press
2014-03-01
|
| Rangatū: | Drug Design, Development and Therapy |
| Urunga tuihono: | http://www.dovepress.com/fc-fusion-technology-and-recombinant-fviii-and-fix-in-the-management-o-peer-reviewed-article-DDDT |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|